中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08765748B2 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer 有权
吲唑基，苯并咪唑基，苯并三唑基取代的二氢吲哚酮衍生物作为可用于治疗癌症的激酶抑制剂

Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
Abstract:
The present invention is directed to a compound is represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof.
Abstract(Chinese):

本发明涉及由结构式（A）表示的化合物或其药学上可接受的盐。 本发明还涉及包含由上述结构式（A）表示的化合物或其药学上可接受的盐和药学上可接受的载体或稀释剂的药物组合物。 还公开了治疗患有癌症的受试者的方法，其中所述方法包括施用治疗有效量的由上述结构式（A）表示的化合物或其药学上可接受的盐。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0